Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.05 Delayed Data As of Jun 05 |  +0.01 / +0.49%Today’s Change | 0.82 Today|||52-Week Range 3.66 | -26.26% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $149.6M |
Company Description
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
Contact Information
Arbutus Biopharma Corp. 701 Veterans Circle Warminster Pennsylvania 18974 |
Employees
Shareholders
| Mutual fund holders | 4.94% |
| Other institutional | 33.71% |
| Individual stakeholders | 29.21% |
Top Executives
| There are no executives to display. |
